FDA's approval last year of Merck's human papillomavirus vaccine, Gardasil, for boys and men ages nine through 26 to protect against genital warts "is prompting yet another round of internal debate" among "parents already uneasy about vaccinating their children," the Chicago Tribune reports. Gardasil, first approved for women and girls in 2006, protects against strains of HPV that can lead to cervical cancer in women and genital warts in both sexes (Black, Chicago Tribune, 5/6)...
More...
More...